title: Biological therapy for Crohn's disease in a liver transplant patient.
authors: Department of Gastroenterology, Torrecardenas Hospital, Almeria, Spain. alvarobendezu@hotmail.com
authors: Rogger Alvaro
authors: RA
authors: Bendezú García
authors: Marco Antonio
authors: MA
authors: Rodríguez Manrique
authors: Alvaro
authors: A
authors: Hernández Martínez
authors: Marta
authors: M
authors: Lázaro Sáez
authors: Gustavo Oliver
authors: GO
authors: Patrón Román
authors: Sergio
authors: S
authors: Amat Alcaraz
authors: Jose Luis
authors: JL
authors: Vega Sáenz
mesh_terms: D000068879:Adalimumab; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D016559:Tacrolimus